Wednesday 6th April 2022 |
Text too small? |
Green Cross Health announces the appointment of Craig Brockliss to the Board, effective 6 April 2022. Mr Brockliss will stand for election at the Annual Shareholders’ Meeting currently scheduled to be held on 25 July 2022.
In accordance with Rule 2.6.1 of the NZX Listing Rules, the Board has determined that Mr Brockliss is a non-independent director due to a disqualifying relationship with substantial product holder Wilton Asset Management Limited, currently the third largest Green Cross Health shareholder.
Craig Brockliss is CEO of the Wilton Capital Group of companies and has more than 20 years’ experience in business, property and private equity investing. Wilton Capital has significant investment interests in both New Zealand, the United States and in the UK.
Wilton Capital has its origins in the pharmaceutical logistics markets in New Zealand and Australia before diversifying into other investments in 2001.
Craig holds a Bachelor of Commerce and a Bachelor of Laws from the University of Auckland and worked for Ernst and Young prior to joining the Wilton Group in 2001.
Kim Ellis
Chair
ENDS
No comments yet
Devon Funds Morning Note - 06 May 2024
EROAD FY24 Results and Webinar Details
thl reduces FY24 NPAT guidance
May 6th Morning Report
Spark New Zealand appoints new director to the Spark Board
AFT to announce full year results on May 23 2024
CRP - Korella North Takes Another Two Steps Forward
May 3rd Morning Report
ASB workers to strike as bank proposes an effective pay cut
Rising tides, sinking stocks: study explores cost of climate change